V

Vedanta Biosciences, Inc.

106 employees

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
human microbiome and mucosal immunology
Business Development
Medical

Date founded

2010

Funding rounds raised

Total raised

$107M

from 28 investors over 28 rounds

V

Vedanta Biosciences, Inc. raised $107M on April 25, 2023

Investors: Korea Investment Partners, Reimagined Ventures, PEAK6, QUAD Investment Management, Seventure Partners, Revelation Partners, Skyviews Life Science and PureTech Health

V

Vedanta Biosciences, Inc. raised $68M on July 21, 2021

Investors: Magnetar Capital, JSR Corporation, Skyviews Life Science, PureTech Health and Shumway Capital

V

Vedanta Biosciences, Inc. raised undisclosed on January 18, 2021

Investors: Hambro Perks

V

Vedanta Biosciences, Inc. raised $77M on September 30, 2020

Investors: Biomedical Advanced Research and Development Authority (BARDA)

V

Vedanta Biosciences, Inc. raised $15M on September 16, 2020

Investors: Oxford Finance LLC

V

Vedanta Biosciences, Inc. raised $5.8M on December 5, 2019

Investors: CARB-X

V

Vedanta Biosciences, Inc. raised $17M on September 23, 2019

Investors: SV Investment, Shinhan Bank, Partners Investment, Shinhan Capital Co., Ltd. and QUAD Investment Management

V

Vedanta Biosciences, Inc. raised $19M on May 13, 2019

Investors: Shumway Capital, JSR Corporation and Partners Investment

V

Vedanta Biosciences, Inc. raised $45M on December 24, 2018

Investors: Seventure Partners, Bristol-Myers Squibb, UK and PureTech Health

FAQ